These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38499184)

  • 1. Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906].
    Aseer KR; Mazucanti CH; O'Connell JF; González-Mariscal I; Verma A; Yao Q; Dunn C; Liu QR; Egan JM; Doyle ME
    Mol Metab; 2024 Apr; 82():101917. PubMed ID: 38499184
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice.
    Aseer KR; Mazucanti CH; O'Connell JF; González-Mariscal I; Verma A; Yao Q; Dunn C; Liu QR; Egan JM; Doyle ME
    Mol Metab; 2024 Apr; 82():101906. PubMed ID: 38423253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells" [Mol Metab 2016 May; 5 (5): 366-378].
    Boothe T; Lim GE; Cen H; Skovsø S; Piske M; Li SN; Nabi IR; Gilon P; Johnson JD
    Mol Metab; 2024 May; 83():101935. PubMed ID: 38604236
    [No Abstract]   [Full Text] [Related]  

  • 4. Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice.
    Comelli F; Bettoni I; Colombo A; Fumagalli P; Giagnoni G; Costa B
    Eur J Pharmacol; 2010 Jul; 637(1-3):62-9. PubMed ID: 20399204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "First contiguous gene deletion causing biotinidase deficiency: The enzyme deficiency in three Sri Lankan children" [Mol. Genet. Metab. Rep. 2 (2016) 81-84].
    Senanayake DN; Jasinge EA; Pindolia K; Wanigasinghe J; Monaghan K; Suchy SF; Wei S; Jaysena S; Wolf B
    Mol Genet Metab Rep; 2017 Jun; 11():95. PubMed ID: 28653700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Molecular regulation of urea cycle function by the liver glucocorticoid receptor" [Mol Metab 4 (10) (2015 Oct) 732-740].
    Okun JG; Conway S; Schmidt KV; Schumacher J; Wang X; de Guia R; Zota A; Klement J; Seibert O; Peters A; Maida A; Herzig S; Rose AJ
    Mol Metab; 2020 Nov; 41():101068. PubMed ID: 32896509
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha" [Mol Metab 7 (2018) 80-89].
    Li G; Brocker CN; Yan T; Xie C; Krausz KW; Xiang R; Gonzalez FJ
    Mol Metab; 2018 Mar; 9():217-219. PubMed ID: 29396375
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219].
    Kondo Y; Tokumaru H; Ishitsuka Y; Matsumoto T; Taguchi M; Motoyama K; Higashi T; Arima H; Matsuo M; Higaki K; Ohno K; Irie T
    Mol Genet Metab; 2017 Mar; 120(3):296-297. PubMed ID: 27733311
    [No Abstract]   [Full Text] [Related]  

  • 10. Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.
    Jourdan T; Szanda G; Cinar R; Godlewski G; Holovac DJ; Park JK; Nicoloro S; Shen Y; Liu J; Rosenberg AZ; Liu Z; Czech MP; Kunos G
    Diabetes; 2017 Apr; 66(4):994-1007. PubMed ID: 28082458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
    Rajesh M; Mukhopadhyay P; Bátkai S; Arif M; Varga ZV; Mátyás C; Paloczi J; Lehocki A; Haskó G; Pacher P
    Geroscience; 2022 Jun; 44(3):1727-1741. PubMed ID: 35460032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice.
    Friedman JE; Sun Y; Ishizuka T; Farrell CJ; McCormack SE; Herron LM; Hakimi P; Lechner P; Yun JS
    J Biol Chem; 1997 Dec; 272(50):31475-81. PubMed ID: 9395482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betacellulin ameliorates hyperglycemia in obese diabetic db/db mice.
    Oh YS; Shin S; Li HY; Park EY; Lee SM; Choi CS; Lim Y; Jung HS; Jun HS
    J Mol Med (Berl); 2015 Nov; 93(11):1235-45. PubMed ID: 26070436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
    Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
    Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
    Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
    J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Next generation sequencing of patients with mut methylmalonic aciduria: Validation of somatic cell studies and identification of 16 novel mutations." [Mol. Genet. Metab. (Aug 2016); 118(4): 264-71].
    Chu J; Pupavac M; Watkins D; Tian X; Feng Y; Chen S; Fenter R; Zhang VW; Wang J; Wong LJ; Rosenblatt DS
    Mol Genet Metab; 2017 Mar; 120(3):295. PubMed ID: 28284539
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice.
    Taki T; Yokono K; Amano K; Hatamori N; Hirao Y; Tominaga Y; Maeda S; Kasuga M
    Diabetologia; 1993 May; 36(5):391-6. PubMed ID: 8314442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "A glimpse into past, present, and future DNA sequencing" [Mol. Genet. Metab. 110 (2013) 3-24].
    Morey M; Fernández-Marmiesse A; Castiñeiras D; Fraga JM; Couce ML; Cocho JA
    Mol Genet Metab; 2015 Mar; 114(3):484. PubMed ID: 25877474
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Interactions between metabolism and chromatin in plant models" [Mol Metab 38 (Aug 2020) 100951].
    Lindermayr C; Rudolf EE; Durner J; Groth M
    Mol Metab; 2020 Nov; 41():101069. PubMed ID: 32891669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.